Northland Securities Starts Biolase (BIOL) at Outperform
Tweet
Share
E-mailGet Alerts BIOL Hot Sheet
Price: $0.15 --0%
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 10 | New: 13
Rating Summary:
6 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 15 | Down: 10 | New: 13
Join SI Premium – FREE
Northland Securities initiates coverage on Biolase (NASDAQ: BIOL) with a Outperform. PT $4.00.
For an analyst ratings summary and ratings history on Biolase click here. For more ratings news on Biolase click here.
Shares of Biolase closed at $1.66 yesterday.
For an analyst ratings summary and ratings history on Biolase click here. For more ratings news on Biolase click here.
Shares of Biolase closed at $1.66 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lake Street Capital Markets Starts Research Solutions Inc. (RSSS) at Buy
- Leerink Partners Starts Cartesian Therapeutics (RNAC) at Outperform
- Rosenblatt Starts NICE Systems Ltd (NICE) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Northland SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
